These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24641467)

  • 21. Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease.
    Garg SK; Velayos FS; Kisiel JB
    Gastroenterol Clin North Am; 2017 Sep; 46(3):515-529. PubMed ID: 28838412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma and levodopa.
    Rosin MA; Braun M
    Cutis; 1984 Jun; 33(6):572-4. PubMed ID: 6744949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies.
    Fulchiero GJ; Salvaggio H; Drabick JJ; Staveley-O'Carroll K; Billingsley EM; Marks JG; Helm KF
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S65-7. PubMed ID: 17434043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases.
    Rossi CR; Pasquali S; Mocellin S; Vecchiato A; Campana LG; Pilati P; Zanon A; Nitti D
    Ann Surg Oncol; 2010 Nov; 17(11):3000-7. PubMed ID: 20429035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.
    Liénard D; Lejeune FJ; Ewalenko P
    World J Surg; 1992; 16(2):234-40. PubMed ID: 1561804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the impact of biologics on surgical complications in Crohn's disease.
    Chang MI; Cohen BL; Greenstein AJ
    Inflamm Bowel Dis; 2015 Jun; 21(6):1472-7. PubMed ID: 25811432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of malignant melanoma of the skin.
    Evans S
    Br Med J; 1980 Feb; 280(6211):403. PubMed ID: 7362994
    [No Abstract]   [Full Text] [Related]  

  • 28. Diazepam and malignant melanoma.
    Adam S; Vessey M
    Lancet; 1981 Dec; 2(8259):1344. PubMed ID: 6118737
    [No Abstract]   [Full Text] [Related]  

  • 29. Cheilitis granulomatosa and Crohn's disease : a case report.
    Seghers AK; Grosber M; Urbain D; Mana F
    Acta Gastroenterol Belg; 2019; 82(2):326-328. PubMed ID: 31314197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic review.
    El-Hussuna A; Theede K; Olaison G
    Dan Med J; 2014 Dec; 61(12):A4975. PubMed ID: 25441731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levodopa and malignant melanoma.
    Robinson E; Wajsbort J; Hirshowitz B
    Arch Pathol; 1973 Mar; 95(3):213. PubMed ID: 4686512
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of metastatic cutaneous Crohn disease with certolizumab.
    Kiuru M; Camp B; Adhami K; Jacob V; Magro C; Wildman H
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [When should anti-TNF-alpha treatment in Crohn disease be terminated?].
    Moum B
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):474. PubMed ID: 20224609
    [No Abstract]   [Full Text] [Related]  

  • 34. Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
    Haebich G; Mughal A; Tofazzal N
    Clin Exp Dermatol; 2016 Jun; 41(4):433-4. PubMed ID: 26577239
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fatal fulminant varicella-zoster virus hepatitis in a female patient with Crohn's disease treated by an anti-TNF-alpha agent].
    Mériglier E; Coudroy R; Agius G
    Med Mal Infect; 2014 Oct; 44(10):484-6. PubMed ID: 25263938
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant melanoma and hormone replacement therapy.
    Jeffery SL; Lewis JS
    Br J Plast Surg; 2000 Sep; 53(6):539. PubMed ID: 10927692
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surpassing conventional therapies: the role of biologic therapy.
    Baldassano RN
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S19-26. PubMed ID: 11685971
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
    Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
    Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple malignant melanomas in a patient with RA treated with methotrexate.
    Potter T; Hardwick N; Mulherin D
    J Rheumatol; 1998 Nov; 25(11):2282-3. PubMed ID: 9818680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.